<DOC>
	<DOC>NCT01998477</DOC>
	<brief_summary>The study is designed to evaluate the safety of TIVa or TIVb vaccine in children 3 to &lt; 18 years of age who are at risk of complications of influenza disease due to underlying diseases.</brief_summary>
	<brief_title>A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to &lt;18 Years of Age at Risk for Influenza-Related Complications</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals 3 through 17 years of age with underlying medical conditions that indicate an increased risk of complications from influenza infection. Further eligibility criteria may be discussed by contacting the site(s) Individuals with any fatal prognosis of an underlying medical condition (&lt;12 month life expectancy). Individuals hospitalized at the time of enrolment. Individuals with a history of any anaphylaxis, serious vaccine reactions, or hypersensitivity to any of the vaccine components. Further eligibility criteria may be discussed by contacting the site(s)</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Flu</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
</DOC>